One of the largest distributors of pharmaceuticals in the United States, the Valley Forge-headquartered AmerisourceBergen Corp., will pay $260 million in penalties after pleading guilty in a subsidiary’s scheme that put the health of thousands of cancer patients at risk.
AmerisourceBergen Specialty Group operated divisions in Alabama — Medical Initiatives Inc. and Oncology Supply Co. — that were not registered with the Food and Drug Administration.
Between 2001 and 2014, the Alabama divisions illegally repackaged millions of syringes that had been prefilled with medicines commonly prescribed to reduce the side effects of chemotherapy.
